A clinical case of oligosymptomatic “amiodaron lung” clinical course

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Timely diagnosis of drug-induced lung injury is a pressing clinical challenge, as in majority of cases, discontinuing the drug helps for resolution of the pathological process. Amiodarone is a frequently prescribed medication for cardiac arrhythmias, but it has numerous side effects. Diagnostic difficulties in identifying amiodarone-induced lung injury are associated with late clinical and radiographic manifestations and the absence of specific signs of this condition. Article presents a clinical case of asymptomatic “amiodaron lung”, demonstrating the importance of prevention and early detection of interstitial lung disease associated with amiodarone intake.

About the authors

Natalya V. Pyrikova

Altai State Medical University

Author for correspondence.
Email: allinatali@mail.ru
ORCID iD: 0000-0003-4387-7737
SPIN-code: 5281-3397

MD, Dr. Sci. (Medicine), associate professor, professor of the Department of faculty therapy and geriatrics

Russian Federation, Barnaul

Irina V. Osipova

Altai State Medical University

Email: i.v.osipova@gmail.com
ORCID iD: 0000-0002-6845-6173
SPIN-code: 1904-5154

MD, Dr. Sci.(Medicine), professor, head of the Department of faculty therapy and geriatrics

Russian Federation, Barnaul

Dina V. Petrova

Regional Clinical Hospital, Barnaul

Email: dinapetrova05@mail.ru
ORCID iD: 0009-0005-7419-3401

MD, PhD (Medicine), head of the Department of pulmonology

Russian Federation, Barnaul

Svetlana I. Kytmanova

Regional Clinical Hospital, Barnaul

Email: allinatali@mail.ru
ORCID iD: 0009-0004-6094-8490

MD, general practitioner of the Department of pulmonology

Russian Federation, Barnaul

References

  1. Singh VK, Maheshwari V. Acute respiratory distress syndrome complicated by amiodarone induced pulmonary fibrosis: Don’t let your guard down. J Clin Diagn Res. 2017;11(4):UD01–UD02. PMID: 28571241. PMCID: PMC5449887. https://doi.org/10.7860/JCDR/2017/24710.9674
  2. Hamilton D Sr, Nandkeolyar S, Lan H, Desai P, Evans J, Hauschild C et al. Amiodarone: A comprehensive guide for clinicians. Am J Cardiovasc Drugs. 2020;20(6):549–58. PMID: 32166725. https://doi.org/10.1007/s40256-020-00401-5
  3. Feduska ET, Thoma BN, Torjman MC, Goldhammer JE. Acute amiodarone pulmonary toxicity. J Cardiothorac Vasc Anesth. 2021;35(5):1485–94. PMID: 33262034. https://doi.org/10.1053/j.jvca.2020.10.060
  4. Motawea A, Ahmed DAM, El-Mansy AA, Saleh NM. Crucial role of PLGA nanoparticles in mitigating the amiodarone-induced pulmonary toxicity. Int J Nanomedicine. 2021;16:4713–37. PMID: 34267519. PMCID: PMC8276877. https://doi.org/10.2147/IJN.S314074
  5. Водоевич В.П., Виноградова Т.А., Заяц А.Н., Козеева Ж.В., Лакотко Т.Г., Харук Ю.Е. с соавт. Случай поражения легких амиодароном. Лечебное дело: научно-практический терапевтический журнал. 2020;(1):54–58. [Vodoevich VP, Vinogradova TA, Zayats AN, Kozeeva ZhV, Lakotko TG, Kharuk YuE et al. A case of lung damage by amiodarone. Lechebnoe delo: nauchno-prakticheskiy terapevticheskiy zhurnal = General Medicine: Scientific and Practical Therapeutic Journal. 2020;(1):54–58 (In Russ.)]. EDN: QDFLQC.
  6. Трофименко И.Н., Черняк Б.А. «Амиодароновое» легкое: обзор литературы и собственные наблюдения. Фарматека. 2018;(3):26–33. [Trofimenko IN, Chernyak BA. “Amiodaron lung”: Literature review and own observations. Farmateka. 2018;(3):26–33 (In Russ.)]. EDN: YRSGHZ.
  7. Takla A, Eid F, Ukrani H, Mohamed M, Lee E. Amiodarone-induced lung toxicity: An underrecognized and fatal presentation. Adv Clin Med Res Healthc Deliv. 2024;4(2). https://doi.org/10.53785/2769-2779.1215
  8. Kanagaki S, Suezawa T, Moriguchi K, Nakao K, Toyomoto M, Yamamoto Y et al. Hydroxypropyl cyclodextrin improves amiodarone-induced aberrant lipid homeostasis of alveolar cells. Am J Respir Cell Mol Biol. 2021;64(4):504–14. PMID: 33493427. https://doi.org/10.1165/rcmb.2020-0119OC
  9. Jackevicius CA, Tom A, Essebag V, Eisenberg MJ, Rahme E, Tu JV et al. Population-level incidence and risk factors for pulmonary toxicity associated with amiodarone. Am J Cardiol. 2011;108(5):705–10. PMID: 21704281. https://doi.org/10.1016/j.amjcard.2011.04.024
  10. Mitrofan CE, Cretu A, Mitrofan C, Bar C, Ghiciuc CM. Amiodarone induced lung disease. Arch Clin Cases. 2022;9(3):126–32. PMID: 36176494. PMCID: PMC9512125. https://doi.org/10.22551/2022.36.0903.10217
  11. Baumann H, Fichtenkamm P, Schneider T, Biscoping J, Henrich M. Rapid onset of amiodarone induced pulmonary toxicity after lung lobe resection – a case report and review of recent literature. Ann Med Surg (Lond). 2017;21:53–57. PMID: 28794867. PMCID: PMC5537372. https://doi.org/10.1016/j.amsu.2017.07.034
  12. Горбунов А.А., Миронов С.Е., Кудряшов Н.В., Лемина Е.Ю. Лекарственно-индуцированные поражения органов дыхания. Экспериментальная и клиническая фармакология. 2023;86(2):42–52. [Gorbunov AA, Mironov SE, Kudryashov NV, Lemina EYu. Drug-induced respiratory damage. Eksperimental’naya i klinicheskaya farmakologiya = Experimental and Clinical Pharmacology. 2023;86(2):42–52 (In Russ.)]. EDN: WRENDV. https://doi.org/10.30906/0869-2092-2023-86-2-42-52
  13. Мартьянова Л.И., Харитонова Г.В., Доброхотова Е.Н., Капитан А.В., Кулагина С.В., Усьманкина Т.А. Случаи рентгенологической диагностики амиодаронового поражения легких. Здравоохранение Чувашии. 2020;(3):65–73. [Martyanova LI, Kharitonova GV, Dobrokhotova EN, Captain AV, Kulagina SV, Usmankina TA. Cases of radiological diagnosis of amiodarone pulmonary lesion. Zdravoohranenie Chuvashii = Healthcare in Chuvashia. 2020;(3):65–73 (In Russ.)]. EDN: GCUFWP. https://doi.org/10.25589/GIDUV.2020.92.31.021
  14. Bui A, Han S, Alexander M, Toner G, Irving L, Manser R. Pulmonary function testing for the early detection of drug-induced lung disease: A systematic review in adults treated with drugs associated with pulmonary toxicity. Intern Med J. 2020;50(11):1311–25. PMID: 31588628. https://doi.org/10.1111/imj.14647
  15. Анаев Э.Х. Лекарственно-индуцированное интерстициальное заболевание легких: подходы к диагностике и лечению. Терапевтический архив. 2020;92(3):84–91. [Anaev EKh. Drug-induced interstitial lung disease: approaches to diagnostics and treatment. Terapevticheskiy arkhiv = Therapeutic Archive. 2020;92(3):84–91 (In Russ.)]. EDN: KGLYSC. https://doi.org/10.26442/00403660.2020.03.000399

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2026 “Bionika Media” LLC

License URL: https://journals.eco-vector.com/2412-4036/about/editorialPolicies